Related Experiment Video
Updated: Mar 14, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Narcolepsy with cataplexy in patients aged over 60 years: a case-control study
Petra Kovalská1, David Kemlink1, Soňa Nevšímalová1
1Department of Neurology, Centre of Clinical Neurosciences, First Faculty of Medicine, General University Hospital in Prague, Charles University in Prague, Prague, Czech Republic.
Objective:
Narcolepsy with cataplexy (NC) is a chronic disabling disease; however, there are insufficient data on older NC subjects.
Methods:
A cross-sectional evaluation on health and social status, including intensity and progression of NC symptoms, was performed on 42 NC patients (age 71.9 years ± 7.5) and 46 age-and-sex-matched controls (age 72.2 years ± 7.0).
Results:
A greater proportion of patients than controls suffered from hypertension and type 2 diabetes. More controls had a history of treated depression; however, according to the Geriatric Depression Scale, more NC patients scored in the range of depression. There were no significant differences in Addenbrook Cognitive Examination scores. Average physical fitness assessed by the Short Physical Performance Battery was lower in the NC group. The frequency of meeting with family, friends, and participation in hobbies or sports did not differ between the two groups.
Conclusions:
Symptoms of NC were present throughout life. Comorbidities and lower physical fitness, which are known to be present in young and middle-aged NC subjects, were also present in older patients. Although NC subjects were less professionally active during their lifetime, they did not differ from controls in important social parameters in older age.
Related Concept Videos
Narcolepsy
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Sleep Apnea
The condition is more prevalent among...
Pharmacodynamics in Geriatric Patients: Effects of Age
REM Sleep Behavior Disorder
RBD is significantly associated with...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

